Abstract
Haematological tumours in the CB17scid mouse produce a disseminated blood-borne disease analogous to that seen in humans. The CB17scid mouse model has been applied to study the efficacy of chemotherapeutic agents on tumours. Using three human tumour-cell lines of haemopoietic origin (CCRF-CEM, Raji, HS-Sultan), we established disseminated tumours in scid mice and studied the in vivo response of these tumours to four chemotherapeutic agents (daunorubicin, idarubicin, ifosfamide, etoposide). The in vitro drug-resistance profiles of the same cell lines to these drugs were also determined by the tetrazolium-dye (MTT) assay. Differences were found in the patterns of resistance and sensitivity of the cell lines in the in vivo and in vitro systems tested. Since the scid mouse model determines the in vivo response of both host and tumour to cytotoxic agents, it may be more valid than the other models in determining drug resistance of haematological malignancies.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 5 November 1995/Accepted: 20 March 1996
Rights and permissions
About this article
Cite this article
Cattan, A., Maung, Z. A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines. Cancer Chemother Pharmacol 38, 548–552 (1996). https://doi.org/10.1007/s002800050525
Issue Date:
DOI: https://doi.org/10.1007/s002800050525